STAT5A and prostate cancer: Upon examination of a series of 80 prostate cancer specimens, autocrine prolactin immunostaining was positive in 54% of samples and local prolactin levels positively correlated with both high Gleason scores and activation of Stat5a/b, the major downstream signaling protein from the PRLRLF to growth [48].